Crescita Therapeutics Inc.
CTX.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.02M | -2.01M | -2.21M | -1.74M | -1.48M |
| Total Depreciation and Amortization | 997.30K | 1.02M | 1.07M | 1.12M | 1.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.10K | 236.30K | 190.20K | 357.40K | 554.20K |
| Change in Net Operating Assets | 2.85M | 1.56M | 1.53M | 499.80K | 1.34M |
| Cash from Operations | 1.97M | 799.20K | 581.50K | 242.10K | 1.54M |
| Capital Expenditure | -1.53M | -1.35M | -764.60K | -98.10K | -98.10K |
| Sale of Property, Plant, and Equipment | 57.20K | 57.20K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.47M | -1.30M | -764.60K | -98.10K | -98.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -441.00K | -433.00K | -426.00K | -417.00K | -408.00K |
| Issuance of Common Stock | -- | 0.00 | 19.00K | 19.00K | 19.00K |
| Repurchase of Common Stock | -320.00K | -396.00K | -519.00K | -471.00K | -393.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00K | -50.00K | -50.00K | -50.00K | -- |
| Cash from Financing | -628.30K | -646.50K | -721.70K | -681.40K | -579.60K |
| Foreign Exchange rate Adjustments | 30.50K | -15.40K | 13.50K | -11.00K | -10.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.30K | -1.16M | -891.30K | -548.50K | 849.20K |